Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (717)
    • Blood Glucose Meters (12)
    • Complications (121)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (104)
    • Monitoring (100)
    • Natural Medicines/Supplements (13)
    • Prevention (32)
    • Treatment (283)
      • Alpha-Glucosidase Inhibitors (20)
      • Amylin Agonist (16)
      • Bromocriptine (5)
      • Combination Products (20)
      • Gliptins (67)
      • Glitazones (96)
      • GLP-1 (29)
      • Incretin Enhancers/Mimetics (59)
      • Insulin (166)
      • Meglitinides (38)
      • Metformin (103)
      • SGLT2 Inhibitors (53)
      • Sulfonylureas (99)
      • Treatment of Pediatric Metabolic Syndrome (3)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (166)
  • Thyroid Disorders (60)
226 - 240 of 283 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) May 2010
Article: medications that stink April 2010
Article: Ongoing concerns about Avandia (rosiglitazone) April 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Other: Senate Concerns about Avandia April 2010
Article: Victoza (VIC-tow-za) will compete with Byetta for type 2 diabetes March 2010
Article: Just because a patient is getting insulin, metformin, or glyburide does not automatically mean that they have life-long diabetes March 2010
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Article: questions about drug expiration and "beyond-use" dating January 2010
Article: differences among insulin pens January 2010
Article: choosing the right needle and syringe size for immunizations and injectable meds December 2009
Article: how to store injectable diabetes meds November 2009
Article: days' supply problems when billing for fixed-quantity meds November 2009
Other: Pancreatitis and Byetta (Exenatide) November 2009
  • « Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved